After two years, pharma volumes pick up pace
NEW DELHI: The domestic pharmaceutical retail market is showing its strongest signs yet of a shift from price-led to demand-led growth. Volume growth crossed 3% in June, the first time…
NPPA fixes prices of 39 drugs, raises anti-rabies immunoglobulin rate
The National Pharmaceutical Pricing Authority (NPPA) has allowed an increase in the retail price of anti-rabies immunoglobulin while fixing the retail prices of 39 drug formulations. According to a gazette…
Rajasthan Healthcare Crisis: 8 Mothers Die Post-C-Section
Jaipur: Eight women have died in Rajasthan following Caesarean-section deliveries. Six deaths occurred within five days at Bhilwara’s Mahatma Gandhi Government Hospital and two recent deaths in Banswara, exposing critical…
Steroid cream misuse fuels spurt in fungal infections
Hyderabad: The indiscriminate use of steroid-based creams for fungal infections, itching and skin rashes is contributing to a growing burden of antifungal resistance (AFR), skin specialists in Hyderabad have warned.Experts said…
Dr Reddy’s delays semaglutide supplies due to API issue
MUMBAI: Dr Reddy’s Laboratories’ plans to capitalize on the early generic semaglutide market have hit a setback after manufacturing issues delayed supplies of the blockbuster diabetes and weight-loss drug, forcing…
India Tightens Rules On Alcohol-Containing Medicines
New rules on alcohol in medicine: The Centre has brought oral medicines containing more than 12% ethyl alcohol and sold in bottles larger than 30 ml under Schedule H1 In…
One more held in spurious plasma racket; police say he supplied 12 boxes
Ahmedabad: The Ahmedabad Rural police have arrested one more accused in the alleged spurious blood plasma racket, taking the total number of arrests in the case to seven. Police said…
Wegovy, Ozempic regain weight as Indian generics fall behind
Mumbai: Novo Nordisk’s weight-loss GLP-1 drug semaglutide branded as Wegovy and Ozempic are clawing back their lost ground with steady month-on-month sales growth as the frenzy of Indian generics begins…
Drug regulator orders fresh safety labels for five common antimicrobials
The updated warnings are intended to alert doctors and patients to rare but potentially serious reactions that surfaced after the medicines entered widespread clinical use. New Delhi: India’s drug regulator…










